|
Peter Van Ess, PharmD, PhD |
|
Dr. Van Ess has over 15 years of pharmaceutical industry and academic experience in clinical pharmacology and laboratory research. He is responsible for overseeing clinical pharmacology, toxicokinetics and is an integral member of the GLDD Pharmacometrics group. From 2002 to present Dr. Van Ess held positions of increasing responsibility with Pharmacia, Pfizer and deCODE Genetics. During this period, Dr. Van Ess was the lead Clinical Pharmacologist supporting a number of regulatory submissions, including INDs, NDAs, sNDAs, and European centralized/decentralized Procedures. Prior to joining the pharmaceutical industry Dr. Van Ess held a number of positions in research and contract laboratories and has extensive experience in preclinical research, molecular biology and the development/validation of bioanalytical methods. He received his BS (Bacteriology and Pharmacy) and PharmD degrees from the University of Wisconsin-Madison and his PhD in Pharmaceutical Sciences from the University of Kentucky-Lexington. |
